Biosketches

Z:\Agnes\Councils\Scientific_Council\SC_ Membership\Biosketches\2017\BiosketchSC2017_Revised.docx
Page 1 of 25
AUSTRALIA (elected in 2016 – mandate expires in 2020)
Adèle GREEN, MBBS, Ph.D.
AUSTRALIA
ADDRESS:
QIMR Berghofer Medical Research Institute
Royal Brisbane Hospital, QLD 4029 Australia
E-mail: [e-mail]
EDUCATION
YEAR
INSTITUTION
QUALIFICATION
1976
1984
1985
1990
2014
University of Queensland
University of Queensland
London School of Hygiene & Tropical Medicine
Australasian Faculty of Public Health Medicine
Australian Academy of Health and Medical Science
MB, BS (Honours I)
PhD Epidemiology
MSc Epidemiology
Fellow
Fellow
PRINCIPAL POSITIONS HELD
YEAR
POSITION AND PLACE OF EMPLOYMENT
1977
1978
1979
1980–1985
1986
1987–1992
1992–1996
1995
1996–1999
1996–2011
1997
2005–2009
2010
2000–2011
2000–
2002–
2009–
2012–
2014–
Previous appointments:
Resident Medical Officer, Mater Misericordiae Hospital, Brisbane
Resident Medical Officer, Cairns Base Hospital, Cairns
Medical Registrar, Mater Misericordiae Hospital, Brisbane
NHMRC Research Scholar and Fellow, QIMR; University of London; Oxford
University
Visiting Lecturer in Medicine, Harvard Medical School, Boston, USA
Senior Research Fellow, QIMR & Tropical Health Program
Principal Research Fellow,
QIMR & Conjoint Associate Professor, Australian
Centre for International Tropical Health and Nutr
ition, University of
Queensland
Honorary Consultant in Medical Research, Mater Misericordiae Hospital,
Brisbane
Head, Epidemiology and Population Health Unit, QIMR
Senior Principal Research Fellow, QIMR
Visiting Medical Research Officer, The Wellcome Trust, London
Adjunct Professor, Griffith University
Acting Director, QIMR
Deputy Director, QIMR
Present appointments:
Head, Cancer and Population Studies Group, QIMR Berghofer Medical Research
Institute (formerly Queensland Institute of Medical Research (QIMR))
Professor, University of Queensland
Conjoint Professor, Queensland University of Technology
Professor, Institute of Inflammation and Repair, University of Manchester
Senior Scientist, QIMR Berghofer Medical Research Institute
Senior Research Scientist, Cancer Research UK Manchester Institute, University
of Manchester
RESEARCH INTERESTS
Cancer etiology, prevention and implementation research, health services and policy.

Z:\Agnes\Councils\Scientific_Council\SC_ Membership\Biosketches\2017\BiosketchSC2017_Revised.docx
Page 2 of 25
AUSTRIA (elected in 2013 – mandate expires in 2017)
Lukas A. HUBER, M.D.
AUSTRIA
ADDRESS:
Director, Biocenter and Cell Biology Division, Medical University Innsbruck
Innrain 80-82
E-mail: [e-mail]
EDUCATION
YEAR
INSTITUTION
QUALIFICATION
1989 University of Innsbruck, Austria M.D.
PRINCIPAL POSITIONS HELD
YEAR
POSITION AND PLACE OF EMPLOYMENT
1990–1993
1993–1995
1995
1996–2002
2002–2004
Since 2005
2007–2008
Since 2009
Since 2012
Since 2015
Postdoctoral scientist, European Molecular Biology Laboratory (EMBL),
Heidelberg, Germany
Maître Assistant, Biochemistry Department, Geneva University, Switzerland
General and Experimental Pathology, University of Innsbruck, Medical
School
Group Leader, Institute of Molecular Pathology, IMP, Vienna, Austria
Professor and Head, Histology and Molecular Cell Biology, Innsbruck
Medical University
Director and Head of the Biocenter, Medical University Innsbruck and
Director, Division of Cell Biology
Co-Director, Integrated Research and Therapy Center (IFTZ), Innsbruck
CSO, Center for Personalized Medicine, ONCOTYROL, Innsbruck
Director, Austrian Drug Screening Institute under the patronage of the
Austrian Academy of Sciences (ÖAW)
Chair, Management Board, Wings4Innovation, Austria
Advisory Board Member, Max Planck Institute for Infection Biology, Berlin
RESEARCH INTERESTS
Spatio-temporal regulation of signal transduction through scaffold complexes and their subcellular
localization, protein transport and sorting, proteomics, mouse genetics, translational cancer
research, entheropathies, lysosomal diseases, orphan diseases.

Z:\Agnes\Councils\Scientific_Council\SC_ Membership\Biosketches\2017\BiosketchSC2017_Revised.docx
Page 3 of 25
BELGIUM (elected in 2016 – mandate expires in 2020)
Roberto SALGADO, M.D., Ph.D.
BELGIUM
ADDRESS:
Department of Pathology, GZA Hospital, Antwerp
&
Breast Cancer Translational Research Laboratory, Jules Bordet Institute, Brussels
E-mail: [e-mail]
EDUCATION
YEAR
INSTITUTION
QUALIFICATION
1998
2004
University of Antwerp, Belgium
University of Antwerp, Belgium
M.D.
Ph.D.
PRINCIPAL POSITIONS HELD
YEAR
POSITION AND PLACE OF EMPLOYMENT
2006–2010
2006–
2010–
Pathology Resident and Lead of the Molecular Pathology Unit and Quality
Assurance Unit, Jules Bordet Institute, Brussels
Member, Breast Cancer Translational Research Laboratory, Jules Bordet
Institute, Brussels and
Member, EORTC, co-lead of the Pathobiology Group and SPECTA-lead
Pathology Resident, GZA Hospitals, Antwerp
RESEARCH INTERESTS
Molecular pathology, solid tumours, in particular breast cancer, circulating tumour biomarkers,
next generation sequencing technologies, validation of biomarkers, innovative clinical trials
incorporating genomics, quality assurance of genomic technologies.

Z:\Agnes\Councils\Scientific_Council\SC_ Membership\Biosketches\2017\BiosketchSC2017_Revised.docx
Page 4 of 25
BRAZIL (elected in 2013 – mandate expires in 2017)
Luis Felipe Ribeiro PINTO, Ph.D.
BRAZIL
ADDRESS:
Head of Molecular Carcinogenesis Program
Head of Education, Brazilian National Cancer Institute (INCA), Rio de Janeiro
E-mail: [e-mail]
EDUCATION
YEAR
INSTITUTION
QUALIFICATION
1989
1994
Federal University, Rio de Janeiro
University College London, UK
Degree in Pharmacy
Ph.D. (Biochemistry and
Molecular Biology)
PRINCIPAL POSITIONS HELD
YEAR
POSITION AND PLACE OF EMPLOYMENT
1996–
2003–2007
2007–2013
2012–
2010–
Reader, Biochemistry Departement, State University, Rio de Janeiro (UERJ)
Head of Post-Graduation in Biology (UERJ)
Head of Post-Graduation in Oncology, Brazilian National Cancer Institute
(INCA)
Head of Education (INCA)
Head of Molecular Carcinogenesis Program (INCA)
RESEARCH INTERESTS
Mechanisms of carcinogenesis; molecular epidemiology; epigenetics and somatic mutations in
relation to etiological factors; developing biomarkers of early detection, prognosis or targeted
therapies in upper aerodigestive tract tumours.

Z:\Agnes\Councils\Scientific_Council\SC_ Membership\Biosketches\2017\BiosketchSC2017_Revised.docx
Page 5 of 25
CANADA (elected in 2013 – mandate expires in 2017)
John J. SPINELLI, B.Sc., M.Sc., Ph.D.
CANADA
ADDRESS:
British Columbia Cancer Agency
675 10th Avenue West
Vancouver, BC, Canada V5Z 1L3
E-mail: [e-mail]
EDUCATION
YEAR
INSTITUTION
QUALIFICATION
1979
1981
1994
Simon Fraser University
Simon Fraser University
Simon Fraser University
B.Sc. (Mathematics & Psychology)
M.Sc. Mathematics (Statistics)
Ph.D. Mathematics (Statistics)
PRINCIPAL POSITIONS HELD
YEAR
POSITION AND PLACE OF EMPLOYMENT
1995–1999
1995–2000
1999–2004
2000–2005
2005–2009
2009–2014
1999–current
2004–current
2006–current
2009–current
2011–current
2016–current
Faculty Biostatistician, St Paul’s Hospital, Centre for Health Evaluation &
Outcome Sciences
Assistant Professor, UBC, Department of Health Care and Epidemiology
Senior Scientist, BCCA, Cancer Control Research Program
Associate Professor, UBC, Department of Health Care and Epidemiology
Professor, UBC, Department of Health Care and Epidemiology
Co-lead, Epidemiology & Biostatistics Theme, UBC, School of Population and
Public Health
Adjunct Professor, Simon Fraser University, Department of Statistics and
Actuarial Science
Distinguished Scientist, BCCA, Cancer Control Research Program
Associate Member, UBC, Department of Statistics
Professor, UBC, School of Population and Public Health
Head, BCCA, Cancer Control Research Program
Acting Vice-President, Population Oncology
RESEARCH INTERESTS
Biostatistical and epidemiological methods; genetic and environmental risks for cancer,
particularly lymphoproliferative malignancies and breast cancer.